MarketCap
Puma Biotechnology PBYI
€ 9.53
5.0%
Facebook
X
Telegram
Land |
 Vereinigte Staaten |
IPO-Jahr |
- |
Branche |
Pharmaeinzelhändler |
Börse |
NASDAQ GLOBAL |
Anteile |
50 M |
Marktkapitalisierung |
$ 535 M |
EBITDA (LTM) |
$ 48.2 M |
P/E (LTM) |
15.403226 |
P/S (LTM) |
2.091376 |
EPS (LTM) |
0.62 |
Andere Aktien der Branche "Pharmaeinzelhändler"
| Name | Preis | % 24h | Marktkapitalisierung | Börse | Land | |
|---|---|---|---|---|---|---|
 |
BeyondSpring
BYSI
|
$ 0.68 | 9.47 % | $ 28 M | Nasdaq Capital Market | USA |
 |
Alkermes plc
ALKS
|
$ 45.87 | 0.38 % | $ 7.55 B | Nasdaq Global Select Market |  Irlanda |
 |
Altimmune
ALT
|
$ 2.1 | 2.94 % | $ 185 M | Nasdaq Global Market | USA |
 |
Arcturus Therapeutics Holdings
ARCT
|
$ 10.84 | 13.63 % | $ 297 M | Nasdaq Global Market,SPB |  Israel |
 |
Arrowhead Pharmaceuticals
ARWR
|
$ 61.68 | 3.61 % | $ 8.25 B | Nasdaq Global Select Market,SPB | USA |
 |
Atara Biotherapeutics
ATRA
|
$ 8.4 | 2.44 % | $ 105 M | Nasdaq Global Select Market,SPB | USA |
 |
Aurinia Pharmaceuticals
AUPH
|
$ 17.11 | 3.35 % | $ 2.3 B | Nasdaq Global Market |  Canada |
 |
Cullinan Management
CGEM
|
$ 12.53 | -20.44 % | $ 755 M | Nasdaq Global Select Market | USA |
 |
BioNTech SE
BNTX
|
$ 90.3 | 3.89 % | $ 21.8 B | Nasdaq Global Select Market |  Germany |
 |
Collegium Pharmaceutical
COLL
|
$ 23.66 | -0.32 % | $ 749 M | Nasdaq Global Select Market | USA |
 |
Corbus Pharmaceuticals Holdings
CRBP
|
$ 3.59 | -7.24 % | $ 47.8 M | Nasdaq Global Market | USA |
 |
Enlivex Therapeutics Ltd.
ENLV
|
$ 1.4 | -4.11 % | $ 64 M | Nasdaq Capital Market | Israel |
 |
AnaptysBio
ANAB
|
$ 47.52 | -0.44 % | $ 1.38 B | Nasdaq Global Select Market,SPB | USA |
 |
Assembly Biosciences
ASMB
|
$ 19.81 | -0.55 % | $ 222 M | Nasdaq Global Select Market,SPB | USA |
 |
Adagene
ADAG
|
$ 2.43 | 3.4 % | $ 143 M | Nasdaq Global Market |  China |
 |
Benitec Biopharma
BNTC
|
$ 9.07 | 7.98 % | $ 422 M | Nasdaq Capital Market | USA |
 |
Denali Therapeutics
DNLI
|
$ 20.93 | 7.61 % | $ 3.61 B | Nasdaq Global Select Market,SPB | USA |
 |
Amarin Corporation plc
AMRN
|
$ 12.29 | 1.99 % | $ 5.1 B | Nasdaq Global Market | Irlanda |
 |
Editas Medicine
EDIT
|
$ 2.72 | 4.62 % | $ 241 M | Nasdaq Global Select Market,SPB | USA |
 |
Agios Pharmaceuticals
AGIO
|
$ 31.42 | 0.71 % | $ 1.82 B | Nasdaq Global Select Market,SPB | USA |
 |
Cue Biopharma
CUE
|
$ 19.81 | -5.03 % | $ 1.88 B | Nasdaq Capital Market,SPB | USA |
 |
Equillium
EQ
|
$ 1.39 | -1.42 % | $ 79.7 M | Nasdaq Global Market | USA |
 |
Black Diamond Therapeutics
BDTX
|
$ 1.9 | 4.97 % | $ 108 M | Nasdaq Global Select Market,SPB | USA |
 |
Abeona Therapeutics
ABEO
|
$ 4.22 | -0.82 % | $ 223 M | Nasdaq Capital Market | USA |
 |
ACADIA Pharmaceuticals
ACAD
|
$ 21.49 | 4.47 % | $ 3.62 B | Nasdaq Global Select Market,SPB | USA |
 |
Atossa Therapeutics
ATOS
|
$ 2.12 | -9.01 % | $ 18.3 M | Nasdaq Capital Market | USA |
 |
Cleveland BioLabs, Inc.
CBLI
|
- | -7.31 % | $ 49 M | Nasdaq Capital Market | USA |
 |
AC Immune SA
ACIU
|
$ 2.25 | 7.66 % | $ 227 M | Nasdaq Global Market |  Schweiz |
 |
Five Prime Therapeutics, Inc.
FPRX
|
- | - | $ 1.77 B | Nasdaq Global Select Market | USA |
 |
ADC Therapeutics SA
ADCT
|
$ 1.72 | 10.65 % | $ 219 M | NYSE | Schweiz |
 |
Harmony Biosciences Holdings
HRMY
|
$ 34.48 | -6.87 % | $ 1.98 B | Nasdaq Global Select Market | USA |
 |
Ardelyx
ARDX
|
$ 3.29 | 8.42 % | $ 793 M | Nasdaq Global Market | USA |
 |
Akebia Therapeutics
AKBA
|
$ 0.69 | -4.49 % | $ 177 M | Nasdaq Global Market | USA |
 |
Alector
ALEC
|
$ 2.29 | 11.61 % | $ 236 M | Nasdaq Global Select Market,SPB | USA |
 |
ALX Oncology Holdings
ALXO
|
$ 1.36 | 5.04 % | $ 73 M | Nasdaq Global Select Market,SPB | USA |
 |
Amneal Pharmaceuticals
AMRX
|
$ 19.93 | -1.36 % | $ 6.25 B | NYSE | USA |
 |
Arbutus Biopharma Corporation
ABUS
|
$ 4.03 | 3.74 % | $ 772 M | Nasdaq Global Select Market | Canada |
 |
Agenus
AGEN
|
$ 6.99 | 4.72 % | $ 208 M | Nasdaq Capital Market | USA |
 |
Immutep Limited
IMMP
|
$ 2.93 | -2.17 % | $ 4.27 B | Nasdaq Global Market |  Australia |
 |
AbCellera Biologics
ABCL
|
$ 12.14 | -0.37 % | $ 3.63 B | Nasdaq Global Select Market | Canada |
 |
Artelo Biosciences
ARTL
|
$ 2.33 | -2.92 % | $ 441 K | Nasdaq Global Select Market | USA |
 |
Aptevo Therapeutics
APVO
|
$ 1.37 | 0.74 % | $ 432 K | Nasdaq Capital Market | USA |
 |
Aligos Therapeutics
ALGS
|
$ 5.03 | 5.89 % | $ 49.7 M | Nasdaq Global Select Market | USA |
 |
Aclaris Therapeutics
ACRS
|
$ 3.67 | -2.01 % | $ 450 M | Nasdaq Global Select Market | USA |
 |
Adaptive Biotechnologies Corporation
ADPT
|
$ 26.7 | 3.49 % | $ 4.05 B | Nasdaq Global Select Market,SPB | USA |
 |
Cellectar Biosciences
CLRB
|
$ 1.24 | -5.34 % | $ 3.23 M | Nasdaq Capital Market | USA |
|
Larimar Therapeutics
LRMR
|
$ 2.78 | 9.25 % | $ 231 M | Nasdaq Global Market | USA |
 |
Biofrontera AG
BFRA
|
- | -8.24 % | $ 105 M | Nasdaq Capital Market | Germany |
 |
Catabasis Pharmaceuticals, Inc.
CATB
|
- | -6.97 % | $ 657 M | Nasdaq Global Market | USA |
 |
Capricor Therapeutics
CAPR
|
$ 8.81 | 6.92 % | $ 409 M | Nasdaq Capital Market | USA |